TrialJAMA oncology2020

Efficacy and Safety of Pembrolizumab Plus Docetaxel vs Docetaxel Alone in Patients With Previously Treated Advanced Non-Small Cell Lung Cancer: The PROLUNG Phase 2 Randomized Clinical Trial.

Oscar Arrieta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.